Before getting lost in the vast options a decentralised clinical trial (DCT) setup provides, sponsors considering a DCT The post Upholding regulatory compliance...
As we close out the year, pharmaphorum’s editorial team sat down together for a roundtable discussion of some The post A few of 2022’s biggest pharma...
Molecular predictors of response to obesity treatment are key in combating the obesity epidemic. A blood test being developed by Phenomix Sciences in collaboration...
There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T The post After a slow start for expensive...
To conclude pharmaphorum’s look back at day one of The Economist’s 8th Annual World Cancer Series congress in The post Economist Impact: World Cancer...
Construction will start early next year of a new manufacturing centre in the UK with the capacity to The post UK, Moderna formalise 10-year vaccines alliance...
It seems like a slam dunk. Why not repurpose already approved or well-studied drug candidates for conditions where treatments are desperately needed? Wouldn’t...
As the COVID pandemic broke open quite clearly, never has there been a greater need for innovation to treat psychological disorders. With the World Health...
In the past two decades, global spending on health has doubled. Yet, optimal healthcare remains out of reach The post Transforming healthcare through sustainable...
The EU has published new recommendations aiming to encourage the use of decentralised clinical trials (DCTs) – and The post EU regulators issue guidance...
Without sustained efforts to increase the application of streamlined approaches, and a more supportive regulatory environment for those who do choose to...
MUSC Hollings Cancer Center oncologists found that using a combination monoclonal antibody (tixagevimab-cilgavimab) against the SARS-CoV-2 spike protein...
Credit: Digital Science / Nature Index Japan’s government has drawn criticism from some of the nation’s researchers following a new analysis that shows...
Co-chaired by Lord James O’Shaughnessy and Professor Mike Bewick, former deputy national medical director of NHS England (present The post NHS Innovation...
New AI technology holds the key to improving knowledge exchange and implementation in real-world clinical practice.
An effective nasal vaccine could stop the virus that causes COVID-19 right at its point of entry. But devising one that works has been a challenge...
Moderna and Merck hailed preliminary results from a combination therapy as a breakthrough, but there are important nuances to consider.
Even as their clients are trying to make clinical trials more diverse and equitable, agencies are continuing their DE&I efforts to build a culture...
Over the past few years, many clinical study administrators wanted to use the bring your own device (BYOD) The post Bringing the Benefits of eCOA BYOD...
A review of the latest executive moves in the pharma industry over the past several months.
FDA Says Ivermectin Doesn't Work Against COVID-19 But Points To Studies That Show It Does Authored by Zachary Stieber via The Epoch Times...
Just as the life sciences industry is getting vocal about how it’s faring, given the prospect of having The post The mysterious UK Life Sciences Council...
Global analytics company Clarivate™ has named Insilico Medicine Founder and CEO Alex Zhavoronkov, PhD, as a Highly Cited Researcher for 2022. Fewer than...
Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck The post How a new investment...
Cambridge scientists have identified an off-patent drug that can be repurposed to prevent COVID-19 – and may be capable of protecting against future...
The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting...
Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry. The post Addressing leadership...
To help address the need for more content-focused solutions to reach HCPs more effectively, Havas Health & You has formed a global partnership with...
NEW YORK and LA JOLLA, CA—While scientists have struggled in the past to create an effective vaccine against HIV, a novel vaccine design strategy being...
Enrolling for clinical trials has become more challenging in recent years, with trial competition, increasingly complex protocols, and The post Improving...